Alzheimer's - What's Next?

A new anti-amyloid drug called Laconemab was shown to significantly reduce cognitive decline in people with early Alzheimer's disease. In the meantime, coming up next week, medicine has begun to reckon with how racial bias is built into some of the very tools and measurements that should be the most objective. We'll talk about a medical device that's critical to patient care, but doesn't seem to work the same on everybody.